Ultragenyx Pharma (RARE) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 17.23 +0.48 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.75 | 52 Week High | $117.12 | |||
| Open | $16.73 | 52 Week Low | $46.52 | |||
| Day High | $17.35 | P/E | N/A | |||
| Day Low | $16.47 | EPS | $-1.97 | |||
| Volume | 1,233,091 | |||||
